Variant report

Variant	nsv561643
Chromosome Location	chr13:51286083-51306330
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:130)
CpG islands
(count:0)
Chromatin interactive
region (count:3)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:130 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr13:51288094-51288355	HepG2	liver:	n/a	chr13:51288178-51288189
2	CEBPB	chr13:51288169-51288243	A549	lung:	n/a	chr13:51288178-51288189
3	CEBPB	chr13:51288176-51288420	K562	blood:	n/a	chr13:51288178-51288189
4	CEBPB	chr13:51288049-51288417	IMR90	lung:	n/a	chr13:51288178-51288189
5	CHD1	chr13:51305579-51305897	GM12878	blood:	n/a	n/a
6	CTCF	chr13:51288320-51288470	GM12871	blood:	n/a	n/a
7	CTCF	chr13:51288300-51288450	AG10803	skin:	n/a	n/a
8	CTCF	chr13:51288360-51288510	HA-sp	spinal cord:	n/a	n/a
9	CTCF	chr13:51288340-51288490	HPAF	blood vessel:	n/a	n/a
10	CTCF	chr13:51288380-51288530	HPAF	blood vessel:	n/a	n/a
11	CTCF	chr13:51288020-51288170	AG04449	skin:	n/a	n/a
12	CTCF	chr13:51288220-51288370	AG04449	skin:	n/a	n/a
13	CTCF	chr13:51289180-51289330	GM12866	blood:	n/a	n/a
14	CTCF	chr13:51288380-51288530	HBMEC	blood vessel:	n/a	n/a
15	CTCF	chr13:51288380-51288530	GM12872	blood:	n/a	n/a
16	CTCF	chr13:51288200-51288350	NHEK	skin:	n/a	n/a
17	CTCF	chr13:51288300-51288450	HCFaa	heart:	n/a	n/a
18	CTCF	chr13:51288300-51288450	NHEK	skin:	n/a	n/a
19	CTCF	chr13:51288360-51288510	HBMEC	blood vessel:	n/a	n/a
20	CTCF	chr13:51288160-51288310	NB4	blood:	n/a	n/a
21	CTCF	chr13:51288360-51288510	HAc	cerebellar:	n/a	n/a
22	CTCF	chr13:51288320-51288470	HA-sp	spinal cord:	n/a	n/a
23	CTCF	chr13:51288380-51288530	HCM	heart:	n/a	n/a
24	CTCF	chr13:51288380-51288530	NB4	blood:	n/a	n/a
25	CTCF	chr13:51288320-51288470	HRPEpiC	eye:	n/a	n/a
26	CTCF	chr13:51289720-51289870	SAEC	small airway:	n/a	n/a
27	CTCF	chr13:51288220-51288370	GM12873	blood:	n/a	n/a
28	CTCF	chr13:51288400-51288550	HCPEpiC	choroid plexus:	n/a	n/a
29	CTCF	chr13:51287180-51287330	GM12866	blood:	n/a	n/a
30	CTCF	chr13:51299440-51299590	HBMEC	blood vessel:	n/a	n/a
31	CTCF	chr13:51288700-51288850	HMF	breast:	n/a	n/a
32	CTCF	chr13:51288340-51288490	HCPEpiC	choroid plexus:	n/a	n/a
33	CTCF	chr13:51288340-51288490	AG09309	skin:	n/a	n/a
34	CTCF	chr13:51288420-51288570	HMF	breast:	n/a	n/a
35	CTCF	chr13:51288440-51288590	HMF	breast:	n/a	n/a
36	CTCF	chr13:51288400-51288550	HVMF	connective:	n/a	n/a
37	CTCF	chr13:51288300-51288450	HRE	kidney:	n/a	n/a
38	CTCF	chr13:51288360-51288510	AG10803	skin:	n/a	n/a
39	CTCF	chr13:51288340-51288490	BJ	skin:	n/a	n/a
40	E2F6	chr13:51300288-51300775	H1-hESC	embryonic stem cell:	n/a	chr13:51300543-51300555 chr13:51300544-51300551 chr13:51300544-51300551 chr13:51300544-51300551
41	E2F6	chr13:51300365-51300682	H1-hESC	embryonic stem cell:	n/a	chr13:51300543-51300555 chr13:51300544-51300551 chr13:51300544-51300551 chr13:51300544-51300551
42	EBF1	chr13:51300496-51300562	GM12878	blood:	n/a	chr13:51300508-51300521 chr13:51300508-51300519
43	EP300	chr13:51284325-51286547	SK-N-SH	brain:	n/a	chr13:51284895-51284902
44	FOS	chr13:51296932-51297229	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr13:51305579-51305908	MCF10A-Er-Src	breast:	n/a	n/a
46	FOS	chr13:51305548-51305934	MCF10A-Er-Src	breast:	n/a	n/a
47	FOS	chr13:51297000-51297200	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr13:51305530-51305927	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr13:51294990-51295309	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr13:51295042-51295285	MCF10A-Er-Src	breast:	n/a	n/a

No data

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:51298771..51301176-chr13:51301369..51304366,2	K562	blood:
2	chr13:51298771..51301176-chr13:51301369..51304366,2	K562	blood:
3	chr13:51276998..51279149-chr13:51301224..51304150,2	K562	blood:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DLEU7-4	chr13:51285144-51287376	NONHSAT033864
2	lnc-DLEU7-4	chr13:51289562-51289619	NONHSAT033864
3	lnc-RNASEH2B-3	chr13:51293783-51293846	NONHSAT033843
4	lnc-RNASEH2B-4	chr13:51287754-51289476	NONHSAT033865
5	lnc-RNASEH2B-3	chr13:51297275-51297372	NONHSAT033843

No data

Variant related genes	Relation type
DLEU7	TF binding region

Extended variants
information (count: 700 )
Associated
traits (count: 121 )

Variant overlapped rSNPs/rCNVs (count:700 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2540523	chr13:51286083-51286084	Enhancers Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs73492012	chr13:51286115-51286116	Enhancers Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs144948147	chr13:51286181-51286182	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
4	rs531797633	chr13:51286269-51286270	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
5	rs565957314	chr13:51286386-51286387	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
6	rs9568458	chr13:51286416-51286417	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs372576018	chr13:51286448-51286449	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
8	rs554323171	chr13:51286454-51286455	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
9	rs185099759	chr13:51286463-51286464	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
10	rs17476046	chr13:51286469-51286470	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs188245994	chr13:51286507-51286508	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
12	rs576808888	chr13:51286583-51286584	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
13	rs541010732	chr13:51286679-51286680	Flanking Active TSS Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
14	rs563533844	chr13:51286691-51286692	Flanking Active TSS Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
15	rs554200137	chr13:51286696-51286697	Flanking Active TSS Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs572676540	chr13:51286706-51286707	Flanking Active TSS Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs58754824	chr13:51286730-51286731	Flanking Active TSS Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs561481638	chr13:51286741-51286742	Flanking Active TSS Enhancers Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs531900360	chr13:51286862-51286863	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
20	rs547774255	chr13:51286863-51286864	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
21	rs532534465	chr13:51286906-51286907	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
22	rs73492016	chr13:51286929-51286930	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs566072943	chr13:51286972-51286973	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
24	rs532443016	chr13:51286990-51286991	Flanking Active TSS Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
25	rs41284834	chr13:51287017-51287018	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
26	rs566970513	chr13:51287039-51287040	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
27	rs200385246	chr13:51287077-51287078	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
28	rs529962048	chr13:51287102-51287103	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
29	rs539891436	chr13:51287137-51287138	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
30	rs548049771	chr13:51287149-51287150	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
31	rs569526911	chr13:51287152-51287153	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers	lncRNA	n/a	Overlapped CNVs	n/a
32	rs559560968	chr13:51287222-51287223	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
33	rs2487700	chr13:51287237-51287238	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs140741697	chr13:51287259-51287260	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
35	rs372691233	chr13:51287282-51287283	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs560928686	chr13:51287331-51287332	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
37	rs558407787	chr13:51287347-51287348	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs566218650	chr13:51287348-51287349	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs376901047	chr13:51287351-51287352	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs369301790	chr13:51287364-51287365	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs570509528	chr13:51287387-51287388	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs41284836	chr13:51287408-51287409	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs370851244	chr13:51287417-51287418	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs552954883	chr13:51287511-51287512	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs180991121	chr13:51287562-51287563	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs574450890	chr13:51287600-51287601	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs543353252	chr13:51287611-51287612	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs184573586	chr13:51287631-51287632	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs373986520	chr13:51287671-51287672	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs555255196	chr13:51287676-51287677	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:121)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	16774939	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Trisomy	24170809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	19242612	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	17245344	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Retinoblastoma	21504564	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Mental retardation	17502991	CNVD
Retinoblastoma	17502991	CNVD
Bipolar disorder	18458673	CNVD
Liposarcoma	21253554	CNVD
T-cell lymphomas	19863542	CNVD
Cervical cancer	21062161	CNVD
microdeletion syndrome	19284877	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Multiple myeloma	19135901	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Prostate cancer	16461572	CNVD
Merkel cell carcinoma	19020549	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Glioblastoma multiforme	19435819	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21858162	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Acute myeloid leukemia	21251322	CNVD
Acute myeloid leukemia	17237825	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Myelofibrosis	22110671	CNVD
Hereditary prostate cancer	22028916	CNVD
Glioblastoma multiforme	22286061	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Prostate cancer	17217626	CNVD
Ovarian cancer	21781307	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21990379	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Gastric cancer	17908304	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:268 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:51269400-51296800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr13:51282400-51286600	Weak transcription	HSMMtube	muscle
3	chr13:51282600-51287200	Weak transcription	Primary B cells from peripheral blood	blood
4	chr13:51282600-51287400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr13:51282600-51287400	Enhancers	Fetal Heart	heart
6	chr13:51282800-51286800	Weak transcription	Primary hematopoietic stem cells	blood
7	chr13:51282800-51287000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
8	chr13:51282800-51287400	Weak transcription	Primary B cells from cord blood	blood
9	chr13:51282800-51287600	Weak transcription	Thymus	Thymus
10	chr13:51283000-51286800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr13:51283000-51287000	Weak transcription	Fetal Thymus	thymus
12	chr13:51283600-51286200	Weak transcription	Primary neutrophils fromperipheralblood	blood
13	chr13:51284400-51287400	Enhancers	Fetal Lung	lung
14	chr13:51285000-51287000	Weak transcription	Fetal Intestine Small	intestine
15	chr13:51285000-51289400	Enhancers	Fetal Muscle Leg	muscle
16	chr13:51285000-51290000	Weak transcription	Brain Substantia Nigra	brain
17	chr13:51285200-51288000	Weak transcription	HepG2	liver
18	chr13:51285400-51288200	Enhancers	Fetal Brain Male	brain
19	chr13:51285600-51286400	Enhancers	Brain Cingulate Gyrus	brain
20	chr13:51285600-51286400	Enhancers	Fetal Stomach	stomach
21	chr13:51285600-51286600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr13:51285600-51287000	Enhancers	Dnd41	blood
23	chr13:51285600-51288200	Enhancers	Fetal Brain Female	brain
24	chr13:51285800-51286200	Weak transcription	Brain Hippocampus Middle	brain
25	chr13:51285800-51286200	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr13:51285800-51287200	Enhancers	Ovary	ovary
27	chr13:51285800-51287600	Enhancers	Primary monocytes fromperipheralblood	blood
28	chr13:51286000-51287000	Enhancers	Brain Angular Gyrus	brain
29	chr13:51286200-51286400	Enhancers	Brain Hippocampus Middle	brain
30	chr13:51286200-51286400	Enhancers	Rectal Smooth Muscle	rectum
31	chr13:51286200-51286400	Enhancers	NHDF-Ad	bronchial
32	chr13:51286200-51287800	Enhancers	Primary neutrophils fromperipheralblood	blood
33	chr13:51286200-51288600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr13:51286200-51290600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
35	chr13:51286400-51286600	Flanking Active TSS	NHDF-Ad	bronchial
36	chr13:51286400-51287200	Weak transcription	Fetal Stomach	stomach
37	chr13:51286400-51287200	Weak transcription	Rectal Smooth Muscle	rectum
38	chr13:51286400-51287800	Weak transcription	Brain Hippocampus Middle	brain
39	chr13:51286400-51288000	Enhancers	Adipose Nuclei	Adipose
40	chr13:51286400-51288800	Weak transcription	Brain Cingulate Gyrus	brain
41	chr13:51286400-51288800	Enhancers	HSMM	muscle
42	chr13:51286600-51286800	Active TSS	NHDF-Ad	bronchial
43	chr13:51286600-51287200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr13:51286600-51287200	Enhancers	Skeletal Muscle Male	skeletal muscle
45	chr13:51286600-51289000	Enhancers	HSMMtube	muscle
46	chr13:51286800-51287000	Enhancers	Skeletal Muscle Female	skeletal muscle
47	chr13:51286800-51287400	Enhancers	Fetal Kidney	kidney
48	chr13:51286800-51287400	Flanking Active TSS	NHDF-Ad	bronchial
49	chr13:51286800-51287600	Enhancers	Primary hematopoietic stem cells	blood
50	chr13:51286800-51287800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links